These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31332036)

  • 1. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
    Ye H; Guo X
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
    Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
    Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
    Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
    Meng F; Tan S; Liu T; Song H; Lou G
    Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
    BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
    Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
    Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
    Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
    Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.
    Ma Y; Kong J; Yan G; Ren X; Jin D; Jin T; Lin L; Lin Z
    BMC Cancer; 2014 Jun; 14():414. PubMed ID: 24912939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
    Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
    Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
    Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
    Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.